Biosignaling is a complex process that involves various pathways through which cells communicate and respond to external signals. Understanding these pathways is crucial for grasping how cells regulate their functions. The three primary types of biosignaling pathways include those utilizing G protein-coupled receptors (GPCRs), receptor tyrosine kinases (RTKs), and lipid hormones.
The first category, GPCRs, is characterized by receptors that span the cell membrane seven times and interact with heterotrimeric G proteins composed of alpha, beta, and gamma subunits. Two significant GPCR signal transduction pathways are the adenylate cyclase pathway and the phosphoinositide pathway. In the adenylate cyclase pathway, the effector enzyme adenylate cyclase is activated by the stimulatory G protein (GS), leading to the production of cyclic AMP (cAMP), a secondary messenger that activates protein kinase A (PKA). The activation of PKA requires the binding of four cAMP molecules to its regulatory subunits, releasing the active catalytic subunits that initiate cellular responses. Conversely, the inhibitory G protein (GI) can dampen this signaling, with toxins like cholera and pertussis affecting these pathways and leading to diseases characterized by severe symptoms.
In the phosphoinositide pathway, the alpha subunit of the G protein activates phospholipase C, which cleaves phosphatidylinositol 4,5-bisphosphate (PIP2) into two secondary messengers: diacylglycerol (DAG) and inositol trisphosphate (IP3). IP3 promotes calcium release from the endoplasmic reticulum, while DAG activates protein kinase C (PKC) in conjunction with calcium, leading to various cellular responses.
The second category, receptor tyrosine kinases (RTKs), includes receptors that possess intrinsic tyrosine kinase activity, allowing them to phosphorylate tyrosine residues on target proteins. A notable example is the insulin receptor, which activates insulin receptor substrates (IRS) that branch into multiple signaling pathways. One pathway involves phosphoinositide 3-kinase (PI3K), leading to increased glucose uptake and glycogen synthesis, while another pathway involves the RAS-MAPK cascade, which is crucial for cell growth and differentiation.
Lastly, lipid hormones, due to their hydrophobic nature, can easily cross cell membranes and directly influence metabolic processes and gene expression. This direct signaling mechanism allows for rapid cellular responses compared to the more complex pathways involving membrane-bound receptors.
In summary, biosignaling encompasses a variety of pathways that enable cells to respond to their environment, with GPCRs, RTKs, and lipid hormones playing pivotal roles in these processes. Understanding these pathways is essential for comprehending cellular communication and the physiological responses that result from various stimuli.
12. Biosignaling
Summary of Biosignaling
12. Biosignaling
Summary of Biosignaling: 동영상 및 연습문제
주제 요약
Summary of Biosignaling brings together three major signaling strategies: GPCRs, receptor tyrosine kinases, and lipid hormone signaling. GPCRs are seven-transmembrane receptors coupled to heterotrimeric G proteins with \(\alpha\), \(\beta\), and \(\gamma\) subunits. In the adenylate cyclase pathway, Gs activates adenylate cyclase to produce cAMP, which activates PKA; four cAMP molecules are needed to release two active catalytic subunits of PKA. Gi opposes this pathway, while cholera toxin overstimulates Gs and pertussis toxin inhibits Gi.
In the phosphoinositide GPCR pathway, the alpha adrenergic receptor activates phospholipase C, which cleaves PIP2 into IP3 and DAG. IP3 promotes calcium release from the endoplasmic reticulum, increasing cytoplasmic calcium, while DAG and calcium activate PKC. RTKs signal through tyrosine phosphorylation, including insulin receptor pathways that branch through IRS1 to regulate glucose metabolism, glycogen synthesis, and GLUT4 expression, and through Ras/MAPK signaling for growth responses.
JAK-STAT is an RTK-related pathway that differs because the receptor lacks a covalently bound tyrosine kinase domain and must recruit JAK first; phosphorylated, dimerized STAT acts as a transcription factor in the nucleus. Lipid hormones diffuse through membranes because they are hydrophobic, producing relatively direct effects on metabolism and gene expression.
0
개념
Summary of Biosignaling
영상 길이:
9mSummary of Biosignaling Video Summary
워크시트로 더 똑똑하게 공부하세요.
각 영상을 인쇄 가능한 워크시트로 따라 하세요
0
문제
Which of the following statements is FALSE?
A
Activation of the α-adrenergic receptor leads to increased levels of Calcium in the cytoplasm.
B
Cholera toxin causes the inhibition of Gs GTPase activity, leading to an overstimulated signal.
C
Upon receptor autophosphorylation, JAK2 then binds to the receptor via its SH2 homology domains.
D
4 cAMP molecules are required to activate protein kinase A.
E
Phosphorylated and dimerized STAT5 acts as a transcription factor in the nucleus.
더 연습하고 싶어?
더 많은 세트플래시카드로 이 주제의 정의를 복습해 보세요
더 많은 세트학생들이 이 주제에 대해 묻는 질문은 다음과 같습니다:
Biosignaling pathways primarily include three types: G protein-coupled receptors (GPCRs), receptor tyrosine kinases (RTKs), and lipid hormone signaling. GPCRs are seven-transmembrane receptors that couple with heterotrimeric G proteins composed of alpha (α), beta (β), and gamma (γ) subunits. They activate secondary messengers like cAMP or IP3/DAG to regulate cellular responses. RTKs have intrinsic tyrosine kinase activity, phosphorylating tyrosine residues to trigger pathways such as insulin signaling, which controls glucose metabolism and growth via IRS1, RAS, and MAPK cascades. The JAK-STAT pathway is a variation where the receptor recruits cytosolic JAK kinase to phosphorylate STAT transcription factors. Lipid hormones, being hydrophobic, diffuse through membranes to directly influence gene expression and metabolism. Each pathway uses distinct mechanisms to transmit extracellular signals into cellular responses.
The adenylate cyclase GPCR pathway begins when a ligand binds to a GPCR, activating the stimulatory G protein (Gs). The Gs alpha subunit then activates adenylate cyclase, an effector enzyme that converts ATP into the secondary messenger cyclic AMP (cAMP). cAMP binds allosterically to the regulatory subunits of protein kinase A (PKA), causing the release of two active catalytic subunits. These catalytic subunits phosphorylate target proteins, leading to specific cellular responses. This pathway is tightly regulated, with inhibitory G proteins (Gi) able to suppress adenylate cyclase activity. Understanding this pathway is crucial because it mediates many physiological processes and is targeted by toxins like cholera toxin, which overstimulates Gs, causing disease symptoms.
Phosphoinositide signaling is a GPCR pathway involving the activation of phospholipase C (PLC) by the alpha subunit of a G protein. PLC cleaves the membrane phospholipid PIP2 into two secondary messengers: inositol trisphosphate (IP3) and diacylglycerol (DAG). IP3 diffuses through the cytosol to bind receptors on the endoplasmic reticulum, triggering the release of calcium ions (Ca2+). The increase in Ca2+ and DAG together activate protein kinase C (PKC), which phosphorylates target proteins to elicit cellular responses. This pathway is important for regulating processes like muscle contraction, secretion, and metabolism.
Insulin signaling via RTKs begins when insulin binds to its receptor, activating the receptor's intrinsic tyrosine kinase domain. This leads to phosphorylation of insulin receptor substrate 1 (IRS1), which acts as a signaling hub. IRS1 activates two main pathways: one involving PI3K, PIP3, PDK1, and PKB (Akt), which promotes glucose uptake by increasing GLUT4 expression and glycogen synthesis; and another involving the RAS-MAPK pathway, which regulates cell growth and differentiation. These pathways coordinate metabolic and growth responses to insulin, maintaining glucose homeostasis and cellular function.
The JAK-STAT pathway differs from typical RTK signaling because its receptors lack intrinsic tyrosine kinase domains. Instead, they recruit cytosolic Janus kinases (JAKs) upon ligand binding. Activated JAKs phosphorylate the receptor, creating docking sites for STAT transcription factors. STATs are then phosphorylated by JAKs, dimerize, and translocate to the nucleus to regulate gene expression. This pathway is critical for cytokine signaling, such as erythropoietin (EPO) signaling, and controls immune responses, cell growth, and differentiation.
Lipid hormones are hydrophobic molecules that can diffuse directly through the plasma membrane without requiring membrane-bound receptors. Once inside the cell, they bind to intracellular receptors, often nuclear receptors, which act as transcription factors to regulate gene expression directly. This contrasts with hydrophilic signaling molecules that bind to cell surface receptors and rely on secondary messengers to transmit signals. Lipid hormone signaling thus provides a more direct and often slower but sustained regulation of metabolism and gene expression.
